BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36167772)

  • 1. A novel variant in the transmembrane 4 domain of ANO3 identified in a two-year-old girl with developmental delay and tremor.
    Aihara Y; Shirota M; Kikuchi A; Katata Y; Abe Y; Niihori T; Funayama R; Nakayama K; Aoki Y; Kure S
    J Hum Genet; 2023 Jan; 68(1):51-54. PubMed ID: 36167772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broadening the clinical spectrum: molecular mechanisms and new phenotypes of ANO3-dystonia.
    Ousingsawat J; Talbi K; Gómez-Martín H; Koy A; Fernández-Jaén A; Tekgül H; Serdaroğlu E; Schreiber R; Ortigoza-Escobar JD; Kunzelmann K
    Brain; 2024 Jun; 147(6):1982-1995. PubMed ID: 38079528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Spectrum of ANO3-Report of a New Family and Literature Review.
    Percetti M; Zini M; Soliveri P; Cogiamanian F; Ferrara M; Orunesu E; Ranghetti A; Ferrarese C; Pezzoli G; Garavaglia B; Isaias IU; Sacilotto G
    Mov Disord Clin Pract; 2024 Mar; 11(3):289-297. PubMed ID: 38284143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phenotypic spectrum of DYT24 due to ANO3 mutations.
    Stamelou M; Charlesworth G; Cordivari C; Schneider SA; Kägi G; Sheerin UM; Rubio-Agusti I; Batla A; Houlden H; Wood NW; Bhatia KP
    Mov Disord; 2014 Jun; 29(7):928-34. PubMed ID: 24442708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel ANO3 variant identified in a 53-year-old woman presenting with hyperkinetic dysarthria, blepharospasm, hyperkinesias, and complex motor tics.
    Blackburn PR; Zimmermann MT; Gass JM; Harris KG; Cousin MA; Boczek NJ; Ross OA; Klee EW; Brazis PW; Van Gerpen JA; Atwal PS
    BMC Med Genet; 2016 Dec; 17(1):93. PubMed ID: 27919237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ANO3 mutations in dystonia: A large-scale mutational screening study.
    Olschewski L; Jesús S; Kim HJ; Tunc S; Löns S; Junker J; Zeuner KE; Kühn AA; Kuhlenbäumer G; Schäffer E; Berg D; Kasten M; Ferbert A; Altenmüller E; Brüggemann N; Bauer P; Rolfs A; Jeon B; Bäumer T; Mir P; Klein C; Lohmann K
    Parkinsonism Relat Disord; 2019 May; 62():196-200. PubMed ID: 30712998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANO3 and early-onset dyskinetic encephalopathy.
    Jiménez de Domingo A; Lopez-Martín S; Albert J; Jiménez de la Peña M; Tirado P; Fernández-Mayoralas DM; Fernández-Perrone AL; Calleja-Pérez B; Martínez-García M; Álvarez S; Fernández-Jaén A
    Eur J Med Genet; 2020 Dec; 63(12):104085. PubMed ID: 33045406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expanding clinical and genetic spectrum of ANO3 dystonia.
    Jiang LT; Li LX; Liu Y; Zhang XL; Pan YG; Wang L; Wan XH; Jin LJ
    Neurosci Lett; 2021 Feb; 746():135590. PubMed ID: 33388357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel ANO3 variant in two siblings with different phenotypes.
    Esposito M; Trinchillo A; Piceci-Sparascio F; D'Asdia MC; Consoli F; De Luca A
    Parkinsonism Relat Disord; 2023 Jun; 111():105413. PubMed ID: 37116293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recessive variants in ZNF142 cause a complex neurodevelopmental disorder with intellectual disability, speech impairment, seizures, and dystonia.
    Khan K; Zech M; Morgan AT; Amor DJ; Skorvanek M; Khan TN; Hildebrand MS; Jackson VE; Scerri TS; Coleman M; Rigbye KA; Scheffer IE; Bahlo M; Wagner M; Lam DD; Berutti R; Havránková P; Fečíková A; Strom TM; Han V; Dosekova P; Gdovinova Z; Laccone F; Jameel M; Mooney MR; Baig SM; Jech R; Davis EE; Katsanis N; Winkelmann J
    Genet Med; 2019 Nov; 21(11):2532-2542. PubMed ID: 31036918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical exome sequencing in early-onset generalized dystonia and large-scale resequencing follow-up.
    Zech M; Boesch S; Jochim A; Weber S; Meindl T; Schormair B; Wieland T; Lunetta C; Sansone V; Messner M; Mueller J; Ceballos-Baumann A; Strom TM; Colombo R; Poewe W; Haslinger B; Winkelmann J
    Mov Disord; 2017 Apr; 32(4):549-559. PubMed ID: 27666935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel de novo KDM5C variant in a female with global developmental delay and ataxia: a case report.
    Lippa NC; Barua S; Aggarwal V; Pereira E; Bain JM
    BMC Neurol; 2021 Sep; 21(1):358. PubMed ID: 34530748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare sequence variants in ANO3 and GNAL in a primary torsion dystonia series and controls.
    Zech M; Gross N; Jochim A; Castrop F; Kaffe M; Dresel C; Lichtner P; Peters A; Gieger C; Meitinger T; Haslinger B; Winkelmann J
    Mov Disord; 2014 Jan; 29(1):143-7. PubMed ID: 24151159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recurrent de-novo ANO3 mutation causes early-onset generalized dystonia.
    Tunc S; Denecke J; Olschewski L; Bäumer T; Münchau A; Lessel D; Lohmann K
    J Neurol Sci; 2019 Jan; 396():199-201. PubMed ID: 30502610
    [No Abstract]   [Full Text] [Related]  

  • 15. Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders.
    Mochel F; Rastetter A; Ceulemans B; Platzer K; Yang S; Shinde DN; Helbig KL; Lopergolo D; Mari F; Renieri A; Benetti E; Canitano R; Waisfisz Q; Plomp AS; Huisman SA; Wilson GN; Cathey SS; Louie RJ; Gaudio DD; Waggoner D; Kacker S; Nugent KM; Roeder ER; Bruel AL; Thevenon J; Ehmke N; Horn D; Holtgrewe M; Kaiser FJ; Kamphausen SB; Abou Jamra R; Weckhuysen S; Dalle C; Depienne C
    Brain; 2020 Dec; 143(12):3564-3573. PubMed ID: 33242881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis.
    Charlesworth G; Plagnol V; Holmström KM; Bras J; Sheerin UM; Preza E; Rubio-Agusti I; Ryten M; Schneider SA; Stamelou M; Trabzuni D; Abramov AY; Bhatia KP; Wood NW
    Am J Hum Genet; 2012 Dec; 91(6):1041-50. PubMed ID: 23200863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAA10 dysfunction with normal NatA-complex activity in a girl with non-syndromic ID and a de novo NAA10 p.(V111G) variant - a case report.
    McTiernan N; Støve SI; Aukrust I; Mårli MT; Myklebust LM; Houge G; Arnesen T
    BMC Med Genet; 2018 Mar; 19(1):47. PubMed ID: 29558889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
    Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
    Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders.
    Stolz JR; Foote KM; Veenstra-Knol HE; Pfundt R; Ten Broeke SW; de Leeuw N; Roht L; Pajusalu S; Part R; Rebane I; Õunap K; Stark Z; Kirk EP; Lawson JA; Lunke S; Christodoulou J; Louie RJ; Rogers RC; Davis JM; Innes AM; Wei XC; Keren B; Mignot C; Lebel RR; Sperber SM; Sakonju A; Dosa N; Barge-Schaapveld DQCM; Peeters-Scholte CMPCD; Ruivenkamp CAL; van Bon BW; Kennedy J; Low KJ; Ellard S; Pang L; Junewick JJ; Mark PR; Carvill GL; Swanson GT
    Am J Hum Genet; 2021 Sep; 108(9):1692-1709. PubMed ID: 34375587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to: "Heterogeneous Phenotypic Evolution in ANO3-Related Dystonia Due to the Recurrent p.Glu510Lys Variant".
    Romito LM; Leta V; Garavaglia B; Panteghini C; Zorzi G; Elia AE; Colucci F; Carecchio M; Eleopra R
    Mov Disord; 2024 Mar; 39(3):632-633. PubMed ID: 38525607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.